EXEL
Exelixis, Inc. · Healthcare
CSO, EVP Disc, Trans Research Dana Aftab sold $103K of Exelixis, Inc.
Sold$103,362
$22.47Price
4,600Shares
−1%Stake
What EXEL did after the filing
- The stock from Tue, Sep 5 open, $22.64
- −3.8%
- S&P 500, same days
- −2.9%
Measured over 30 trading days, to the Oct 17 close.
Traded Wed, Aug 30. Filed Fri, Sep 1, 4:15 PM ET, after the close. Returns use the Sep 5 open and the Oct 17 close. Not investment advice.